(E)-3-(7-methoxy-2,4-dihydroindeno[1,2-c]pyrazol-3-yl)-1-(4-methoxyphenyl)prop-2-en-1-one
C21H18N2O3 — CID 155547687
Data last refreshed: (MolForge compound catalog, from PubChem)
About (E)-3-(7-methoxy-2,4-dihydroindeno[1,2-c]pyrazol-3-yl)-1-(4-methoxyphenyl)prop-2-en-1-one
(E)-3-(7-methoxy-2,4-dihydroindeno[1,2-c]pyrazol-3-yl)-1-(4-methoxyphenyl)prop-2-en-1-one (PubChem CID 155547687) has the molecular formula C21H18N2O3 and a molecular weight of 346.39 g/mol. Its IUPAC name is (E)-3-(7-methoxy-2,4-dihydroindeno[1,2-c]pyrazol-3-yl)-1-(4-methoxyphenyl)prop-2-en-1-one.
Molecular Properties
| Compound Name | (E)-3-(7-methoxy-2,4-dihydroindeno[1,2-c]pyrazol-3-yl)-1-(4-methoxyphenyl)prop-2-en-1-one |
|---|---|
| PubChem CID | 155547687 |
| Molecular Formula | C21H18N2O3 |
| Molecular Weight | 346.39 g/mol |
| Exact Mass | 346.13 |
| IUPAC Name | (E)-3-(7-methoxy-2,4-dihydroindeno[1,2-c]pyrazol-3-yl)-1-(4-methoxyphenyl)prop-2-en-1-one |
| SMILES | COc1ccc(C(=O)/C=C/c2[nH]nc3c2Cc2ccc(OC)cc2-3)cc1 |
| InChI | InChI=1S/C21H18N2O3/c1-25-15-6-3-13(4-7-15)20(24)10-9-19-18-11-14-5-8-16(26-2)12-17(14)21(18)23-22-19/h3-10,12H,11H2,1-2H3,(H,22,23)/b10-9+ |
| InChIKey | HXZJXLPRCMJZGO-MDZDMXLPSA-N |
| XLogP | 3.89 |
| TPSA | 64.21 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 26 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 346.39 |
| LogP ≤ 5 | 3.89 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 4 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155547687 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.